Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30

BACKGROUND: The benefits of chemotherapy in node-negative, hormone receptor-positive, and human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients with the 21-gene recurrence score (RS) of 18–30, particularly those with RS 26–30, are not known. METHODS: Using the Surveillance,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res
Hlavní autoři: Park, Seho, Han, Yunan, Liu, Ying, Toriola, Adetunji T., Peterson, Lindsay L., Colditz, Graham A., Kim, Seung Il, Cho, Young Up, Park, Byeong-Woo, Park, Yikyung
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796491/
https://ncbi.nlm.nih.gov/pubmed/31619259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1190-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky